Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Self-Administration Drugs Market: High Healthcare Costs Coupled with Increasing Trend towards Self Administration of Drugs for Various Diseases

Transparency Market Research
Posted on: 30 Sep 16

The drugs that are taken by the patients on their own are known as self administration drugs. These drugs are administered in the body through implantable and non implantable infusion pumps which have an opening that comes in contact with the skin surface for injecting drugs. In addition, oral, over-the-counter and topical prescription drugs are also considered to be self administered drugs. 

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2083

Self administered drugs include Actimmune, Afinitor, Apokyn, Enbrel, Cetrotide, Caprelsa, Cetrotide, Bosulif, Bravelle, Betaseron,Zytiga, Zorbtive, Zolinza, Xgeva, Zavesca, Xeloda, Xtandi, Tev-Tropin, TOBI, Vectibix, Temodar, Tecfidera, Ventavis, Tasigna and Thalomid. Many more drugs are in the market that can be taken by the patients on their own. Infusion pumps play a very crucial role in self administration drugs market. Insulin and certain analgesics are directly injected to the intravenous and cerebrospinal fluid respectively, through the infusion pumps. 

Change in lifestyles will augment the growth of this market since the use of self administered drugs would reduce time for the patient. In addition, reimbursement policies will also boost the growth of this market. Medicare Supplemental Medical Insurance (SMI) covers certain list of self administered drugs that are given for general care of the patient. 

Moreover, shifting of patient population to industrial countries may also trigger the growth of this market. High healthcare costs coupled with increasing trend towards self administration of drugs for various diseases will also enhance the growth of this market. Increase in the number of diabetic patients worldwide will contribute greatly to the growth of this market.

Despite all these factors, growth of this market may get hindered due to various reasons such as side effects due to improper doses of medications and leakage of raw materials of the implants in blood. In addition, stringent caregiver safety legislations will also hamper the growth of this market. The major players operating in the self administration drugs market include Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, Novartis AG and Eli Lilly and Company, among other significant players worldwide.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Editor's Details

MarketTrends
pooja.m@transparencymarketresearch.com

Last updated on: 30/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.